Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

EULAR 2015: Cardiovascular Concerns, Infertility in RA

Thomas R. Collins  |  Issue: September 2015  |  September 15, 2015

The diagnoses of subfertility included 41% that were unexplained, 27% anovulation, 16% male subfertility and 6% endometriosis.

“Unexplained subfertility and anovulation are the most common diagnoses in subfertile female RA patients,” Dr. Brouwer said. Unexplained subfertility especially “is diagnosed more often than in the general subfertile population. Therefore, it is likely that RA-related factors, such as severity of the disease, inflam­mation, and the use of anti-rheumatic drugs, are involved in subfertility in women with RA.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Thomas R. Collins is a freelance medical writer based in Florida.

References

  1. Erhayiem B, McDiarmid A, Swoboda P, et al. Treatment-naïve, early rheumatoid arthritis patients demonstrate vascular and myocardial abnormalities on cardiac MRI. Abstract OP0163. Presented at EULAR, June 12, 2015, Rome, Italy.
  2. Harrold LR, Gandhi, KK, Etzel CJ, et al. The impact of rheumatoid arthritis on patient reported outcomes and quality of life prior to biologic initiation. Abstract OP0160. Presented at EULAR, June 12, 2015, Rome, Italy.
  3. Brouwer J, Fleurbaaij R, Hazes JM et al. Subfertility in female rheumatoid arthritis patients is often unexplained or caused by anovulation. Abstract OP0165. Presented at EULAR, June 12, 2015, Rome, Italy.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsRheumatoid Arthritis Tagged with:cardiovascularinfertilityoutcomepatient careRARheumatoid arthritis

Related Articles

    Cardiovascular Risk in Tocilizumab Therapy for RA

    September 15, 2015

    Observation and research have confirmed that patients with rheumatoid arthritis (RA) are at greater risk of cardiovascular disease than their peers of similar age and gender, and that traditional risk factors and chronic inflammation associated with RA apparently play a significant role in that risk. However, predicting which patients with rheumatoid arthritis are at greater…

    Long-Term Benefits, Risks of Biologic Disease-Modifying Anti-Rheumatic Drugs in Patients with RA

    December 19, 2017

    Two decades have passed since the first biologic disease-modifying anti-rheumatic drug (bDMARD) was approved. Studies on the long-term use of biologics in different disease states, such as for cardiovascular disease (CVD) and malignancy, as well as for knee/hip replacement, reveal some encouraging news. In clinical trials, bDMARDs have been shown to increase the risk of…

    racorn/shutterstock.com

    EULAR Releases 2016 Recommendations on RA Management

    July 14, 2017

    Management of rheumatoid arthritis (RA) is complex. The ever-expanding availability of new drugs requires that rheumatologists and patients constantly consider treatment strategies and targets aimed at both disease control and symptom relief while remaining cognizant of the increasing high cost of emerging medications. Given such complexity, guidelines to inform rheumatologists about the most recent developments…

    A Heart In Danger

    November 1, 2006

    Rheumatologists should monitor and aggressively treat cardiac risk factors in patients with lupus and rheumatoid arthritis

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences